PortfoliosLab logoPortfoliosLab logo
JABLX vs. JNGLX
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

JABLX vs. JNGLX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Janus Henderson VIT Balanced Portfolio (JABLX) and Janus Henderson Global Life Sciences Fund (JNGLX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, JABLX achieves a 3.38% return, which is significantly higher than JNGLX's -2.51% return. Both investments have delivered pretty close results over the past 10 years, with JABLX having a 10.50% annualized return and JNGLX not far behind at 10.41%.


JABLX

1D
-0.55%
1M
2.16%
YTD
3.38%
6M
3.50%
1Y
14.17%
3Y*
13.91%
5Y*
7.88%
10Y*
10.50%

JNGLX

1D
1.13%
1M
-0.29%
YTD
-2.51%
6M
-0.73%
1Y
26.17%
3Y*
9.73%
5Y*
7.15%
10Y*
10.41%
*Multi-year figures are annualized to reflect compound growth (CAGR)

JABLX vs. JNGLX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
JABLX
Janus Henderson VIT Balanced Portfolio
3.38%15.13%15.42%15.41%-16.36%17.20%14.21%22.60%0.68%18.44%
JNGLX
Janus Henderson Global Life Sciences Fund
-2.51%24.84%3.60%7.51%-2.69%6.78%25.66%29.20%4.17%22.13%

Correlation

The correlation between JABLX and JNGLX is 0.44, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.44

Correlation (3Y)
Calculated over the trailing 3-year period

0.55

Correlation (5Y)
Calculated over the trailing 5-year period

0.63

Correlation (10Y)
Calculated over the trailing 10-year period

0.67

Correlation (All Time)
Calculated using the full available price history since Jan 5, 1999

0.72

Over the past year, the correlation between JABLX and JNGLX has dropped to 0.44 - well below their long-term average of 0.72, suggesting their price drivers have been diverging.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

JABLX vs. JNGLX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

JABLX
JABLX Risk / Return Rank: 3333
Overall Rank
JABLX Sharpe Ratio Rank: 3535
Sharpe Ratio Rank
JABLX Sortino Ratio Rank: 3434
Sortino Ratio Rank
JABLX Omega Ratio Rank: 3434
Omega Ratio Rank
JABLX Calmar Ratio Rank: 2424
Calmar Ratio Rank
JABLX Martin Ratio Rank: 3636
Martin Ratio Rank

JNGLX
JNGLX Risk / Return Rank: 4141
Overall Rank
JNGLX Sharpe Ratio Rank: 3838
Sharpe Ratio Rank
JNGLX Sortino Ratio Rank: 3939
Sortino Ratio Rank
JNGLX Omega Ratio Rank: 3535
Omega Ratio Rank
JNGLX Calmar Ratio Rank: 5252
Calmar Ratio Rank
JNGLX Martin Ratio Rank: 4141
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

JABLX vs. JNGLX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Janus Henderson VIT Balanced Portfolio (JABLX) and Janus Henderson Global Life Sciences Fund (JNGLX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


JABLXJNGLXDifference
Sharpe ratioReturn per unit of total volatility

-0.11

Sortino ratioReturn per unit of downside risk

-0.19

Omega ratioGain probability vs. loss probability

1.30

1.31

-0.01

Calmar ratioReturn relative to maximum drawdown

1.82

2.75

-0.94

Martin ratioReturn relative to average drawdown

7.85

8.75

-0.90

JABLX vs. JNGLX - Sharpe Ratio Comparison

The current JABLX Sharpe Ratio is 1.69, which is comparable to the JNGLX Sharpe Ratio of 1.79. The chart below compares the historical Sharpe Ratios of JABLX and JNGLX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


JABLXJNGLXDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.69

1.79

-0.11

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.71

0.45

+0.26

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.95

0.60

+0.35

Sharpe Ratio (All Time)

Calculated using the full available price history

0.93

0.57

+0.36

Drawdowns

JABLX vs. JNGLX - Drawdown Comparison

The maximum JABLX drawdown since its inception was -27.07%, smaller than the maximum JNGLX drawdown of -59.00%. Use the drawdown chart below to compare losses from any high point for JABLX and JNGLX.


Loading charts...

Drawdown Indicators


JABLXJNGLXDifference

Max Drawdown

Largest peak-to-trough decline

-27.07%

-59.00%

+31.93%

Max Drawdown (1Y)

Largest decline over 1 year

-8.10%

-9.68%

+1.58%

Max Drawdown (3Y)

Largest decline over 3 years

-11.89%

-21.17%

+9.28%

Max Drawdown (5Y)

Largest decline over 5 years

-21.30%

-22.21%

+0.91%

Max Drawdown (10Y)

Largest decline over 10 years

-22.47%

-27.37%

+4.90%

Current Drawdown

Current decline from peak

-0.55%

-5.44%

+4.89%

Average Drawdown

Average peak-to-trough decline

-4.71%

-17.65%

+12.94%

Ulcer Index

Depth and duration of drawdowns from previous peaks

1.87%

3.04%

-1.17%

Volatility

JABLX vs. JNGLX - Volatility Comparison

The current volatility for Janus Henderson VIT Balanced Portfolio (JABLX) is 2.52%, while Janus Henderson Global Life Sciences Fund (JNGLX) has a volatility of 4.80%. This indicates that JABLX experiences smaller price fluctuations and is considered to be less risky than JNGLX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


JABLXJNGLXDifference

Volatility (1M)

Calculated over the trailing 1-month period

2.52%

4.80%

-2.28%

Volatility (6M)

Calculated over the trailing 6-month period

6.93%

10.89%

-3.96%

Volatility (1Y)

Calculated over the trailing 1-year period

8.74%

14.86%

-6.12%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

11.16%

15.86%

-4.70%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

11.11%

17.38%

-6.27%

JABLX vs. JNGLX - Expense Ratio Comparison

JABLX has a 0.62% expense ratio, which is lower than JNGLX's 0.80% expense ratio.


Dividends

JABLX vs. JNGLX - Dividend Comparison

JABLX's dividend yield for the trailing twelve months is around 4.99%, more than JNGLX's 4.68% yield.


PositionTTM20252024202320222021202020192018201720162015
JABLX
Janus Henderson VIT Balanced Portfolio
4.99%5.16%2.02%2.01%4.78%1.58%3.14%4.43%5.22%1.71%3.64%5.22%
JNGLX
Janus Henderson Global Life Sciences Fund
4.68%4.56%5.84%4.26%0.25%9.85%7.80%6.23%13.32%0.89%0.30%8.81%

Frequently Asked Questions


JABLX and JNGLX have a correlation of 0.44, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

JNGLX has higher volatility (4.80%) compared to JABLX (2.52%). In terms of maximum drawdown, JABLX dropped -27.07% vs JNGLX's -59.00%.

JNGLX currently has the higher Sharpe Ratio (1.79 vs 1.69), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for JABLX and JNGLX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer